Marina M. Parton
Fulham Road
London, ENG SW36JJ, United Kingdom
London, ENG SW36JJ, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Thermal Ablation of Breast Cancer Liver Metastases Is Associated with Durable Local Control and Chemotherapy-Free Intervals in Selected Patients.
Journal: Cancers
Published: May 18, 2026
Adenoid Cystic Carcinoma of the Breast: Clinicopathological Features and Long-Term Outcomes from a 20-Year Retrospective Cohort.
Journal: Oncology research
Published: May 09, 2026
The Clinical Features and Outcomes of Pseudocirrhosis in Breast Cancer.
Journal: Cancers
Published: July 08, 2024
The emerging predictive and prognostic role of HER2 in HER2-negative early breast cancer: a retrospective study.
Journal: Breast cancer research and treatment
Published: March 10, 2024
Imaging in metastatic breast cancer, CT, PET/CT, MRI, WB-DWI, CCA: review and new perspectives.
Journal: Cancer imaging : the official publication of the International Cancer Imaging Society
Published: November 01, 2022
Neratinib in advanced HER2-positive breast cancer: experience from the royal Marsden hospital.
Journal: Breast cancer research and treatment
Published: April 20, 2022
Vinorelbine After Prior Treatment With Eribulin for Advanced Breast Cancer: A Single-Centre Experience Suggesting Cross-Resistance.
Journal: Clinical breast cancer
Published: January 03, 2022
A review on the added value of whole-body MRI in metastatic lobular breast cancer.
Journal: European radiology
Published: October 04, 2021
Cutaneous toxicities occurring during palbociclib (CDK4/6 inhibitor) and endocrine therapy in patients with advanced breast cancer: a single-centre experience.
Journal: Breast cancer research and treatment
Published: December 15, 2020
Impact of timing of adjuvant chemothapy for early breast cancer: the Royal Marsden Hospital experience.
Journal: British journal of cancer
Published: July 06, 2020
Clinical outcomes in patients with triple negative or HER2 positive lobular breast cancer: a single institution experience.
Journal: Breast cancer research and treatment
Published: June 08, 2020
Last Updated: 09/26/2026